ArticleACS catalysis2025
Organometallic Catalysis Catches up with Enzymatic in the Regeneration of NADH.
Article in ACS catalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Pyridinium amidate (PYA) substituents impact ligand-centered hydride formation and (catalytic) hydride transfer reactivity.Dalton transactions (Cambridge, England : 2003) · 2026Article
- Unique Metal-Ligand Proton Tautomerism Underlying the Reversible Electrocatalytic NADJournal of the American Chemical Society · 2026Article
- Selective Iridium-Catalyzed Reductive Amination Inside Living Cells.Journal of the American Chemical Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A rational design, based on a deep understanding of the reaction mechanism, led to the development of an iridium organometallic catalyst with activity comparable to that of enzymes in the chemical regeneration of NADH, using phosphite as a reducing agent. The innovative structural elements were individuated in replacing pyridine with pyrazine and adding a carbohydrazide moiety in the bidentate amidate supporting ligand. Resulting [Cp*Ir-(pyza-NH
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.